Skip to main content

Research

New
History

Explore

Search
Cases
Professionals

Resources

Blog
Pricing
Docs

Sign in Create account

Cases

CourtFilingsPetition dateMore filters

Case

Funded debt

Stage

Exit

Next hearing

Last activity

Petition date

Court

NeuroproteXeon, Inc. Bankruptcy Case

NeuroproteXeon, Inc.

Chapter 7 · Sale Process

Case No. 19-12676·Delaware·Petition date Dec 16, 2019

Research this case Track this case Sign in

OverviewProfessionals

Key professionals

Financial Advisor

Emerald Capital Advisors

Investment Banker

Lincoln Partners Advisors LLC

Accounting / Auditor

Tronconi Segarra & Associates LLP

Bankruptcy Counsel

Ashby & Geddes, P.A.

Judge: Mary F. Walrath
Petition assets: $1M–$10M
Petition liabilities: $1M–$10M
Industry: Healthcare
Debtors: 4

NeuroproteXeon, Inc. is a pharmaceutical and medical device company headquartered in Orchard Park, New York, focused on developing XENEX™, a xenon gas-based treatment for Post-Cardiac Arrest Syndrome. The company operates through subsidiaries in the U.K. and Germany, utilizing a proprietary closed-circuit delivery device. It holds exclusive patent licenses extending to 2030 and maintains strategic commercialization partnerships with Mallinckrodt Pharma and Linde AG, supported by long-term supply agreements for xenon gas and medical hardware.

Case background, summaries, and key terms are generated from the filings on this docket. Docket entries and documents come from the court.

Report a data error